References
- Advisory Council on the Misuse of Drugs. Reducing drug related deaths,. Stationery Office, London 2000, Home Office Report
- Bertschy G. Methadone maintenance treatment: an update. European Archives of Psychiatry & Clinical Neuroscience 1995; 245: 114–124
- Capelhorn J. R. M., Bell J. Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia 1991; 154: 195–9
- Christo G., Spurrell S., Alcorn R. Validation of the Christo Inventory for Substance‐misuse Services (CISS): a simple outcome evaluation tool. Drug & Alcohol Dependence 2000; 59: 189–197
- Fischer G., Gombas W., Eder H., Jagsch R., Peternell A., Stuhlinger G., Pezawas L., Aschauer A. N., Kasper S. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999; 94: 1337–1347
- Holland R., Vivancos R., Maskrey V., Sadler J., Rumball D., Swift L. The prevalence of problem drug misuse in a rural county of England. Journal of Public Health 2006; 28((2))88–95
- Johnson R. E., Chutuape M. A., Strain E. C., Walsh S. L., Stitzer M. L., Bigelow G. E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 2000; 343: 1290–1297
- King M., Nazareth I., Lampe F., Bower P., Chandler M., Morou M., Sibbald B., Lai R. Impact of participant and physician intervention preferences on randomised controlled trials. A systematic review. Journal of the American Medical Association 2005; 293: 1089
- Kosten T. R., Schottenfeld R., Ziedonis D., Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease 1993; 181((6))358–364
- Ling W., Charuvastra C., Collins J. F. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 1998; 93: 475–486
- Ling W., Wesson D. R., Charuvastra C., Klett C. J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry 1996; 53((5))401–407
- Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: a meta‐analysis. Addiction 1998; 93: 515–532
- Mattick R. P., Ali R., White J. M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomised double‐blind trial with 405 opioid dependent patients. Addiction 2002; 98: 441–452
- Mattick R. P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (Cochrane Review). The Cochrane Library,. 2003, issue 2
- National Treatment Agency, Performance Information. 2006. Available at: http://www.nta.nhs.uk/frameset.asp?u = http://www.nta.nhs.uk/programme/national/monitoring.htm (accessed 10 November 2006)
- Pani P. P., Maremmani I., Pirastu R., Tagliamonte A., Gessa G. L. Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug and Alcohol Dependence 2000; 60((1))39–50
- Petitjean S., Stohler R., Deglon J., Livoti S., Waldvogel D., Uehlinger C., Ladewig D. Double‐blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence 2001; 62: 97–104
- Schottenfeld R. S., Pakes J. R., Oliveto A., Ziedonis D., Kosten T. R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry 1997; 54: 713–20
- Strain E. C., Stitzer M. L., Liebson I. A., Bigelow G. E. Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry 1994a; 151: 1025–1030
- Strain E. C., Stitzer M. L., Liebson I. A., Bigelow G. E. Buprenorphine versus methadone in the treatment of opioid dependent cocaine users. Psychopharmacology 1994b; 116: 401–406
- Uehlinger C., Deglon J., Livoti S., Petitjean S., Waldvogel D., Ladewig D. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study. European Addiction Research 1998; 4 (Suppl 1)13–18
- Walsh S. L., Preston K. L., Stitzer M. L., Cone E. J., Bigelow G. E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clinical Pharmacology and Therapeutics 1994; 55: 569–580